SAN DIEGO, CA – Bionano Genomics Inc. (NASDAQ:BNGO), a company specializing in laboratory analytical instruments, has received a notice from The Nasdaq Stock Market LLC... ByInvesting.com ...

Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on BioNano Genomics (NASDAQ:BNGO) Inc on Monday, setting a price target of $14, which is approximately 86.17% above the... Oppenheimer ...

On Wednesday, BioNano Genomics Inc (BNGO) stock saw a modest uptick, ending the day at $0.3 which represents no change from the prior close of of $0.3. The stock opened at $0.3 and touched a low of $0 ...

BTIG Research has recently reduced BioNano Genomics Inc (BNGO) stock to Neutral rating, as announced on September 10, 2024, according to Finviz. Earlier, on January 5, 2023, Scotiabank had initiated ...

BNGO) is a biotech stock that specializes in th Ideanomics Attachment Modena, Italy, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Energica Inside, the business unit of Energica Motor Company (a majority ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

INND InnerScope Hearing Technologies, Inc.

There was no apparent catalyst for the increase. The stock has been highly volatile since it went public in March: It quadrupled in value over a five-week span before plunging by 41% over the past ...

While investors already knew the share purchase would happen, they responded positively to the news today, pushing up Lucid's stock by as much as 5% today. As of 2:26 p.m. ET Lucid's stock had ...